Author

Jessica Hung

University of California, BerkeleyORCID 0000-0002-7815-1082Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Jessica Hung1 paper · University of California, Berkeley, California;

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell type annotation· 1 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Michel J.P. DuPageiD· 2 shared Alissa BockmaniD· 1 shared Antoine Sauquet· 1 shared Brenna J. GittinsiD· 1 shared Brian M. WeistiD· 1 shared Chenyu ZhangiD· 1 shared Dorothée Saddier AxeiD· 1 shared Grace JaworskiiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Michel J.P. DuPageORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologyScience AdvancesPeer-reviewedJan 23, 2026

Selective disruption of lipid peroxide homeostasis in intratumoral regulatory T cells by targeting FSP1 enhances cancer immunity

Jesse Garcia Castillo, Stephanie L. Silveria, Leo Schirokauer…·Michel J.P. DuPage

This study shows targeting FSP1 in regulatory T cells disrupts their immunosuppression, enhancing anti-tumor immunity without causing autoimmunity.

13 citationstop 1%

mouseexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 26, 2025

Intratumoral Treg ablation is sufficient to mediate tumor control systemically without autoimmunity

Alissa Bockman, Brenna J. Gittins, Chenyu Zhang…·Michel J.P. DuPage

The paper shows that ablating tumor-infiltrating Tregs systemically controls tumors without autoimmunity, primarily through CD4+ T cells and cDC2s.

3 citations

mouseexperimental assay

𝕏 PostBluesky